PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE Trademark

Trademark Overview


On Wednesday, March 3, 2021, a trademark application was filed for PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE with the United States Patent and Trademark Office. The USPTO has given the PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE trademark a serial number of 90558538. The federal status of this trademark filing is REGISTERED as of Tuesday, July 26, 2022. This trademark is owned by Precision Medicine Group, LLC. The PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry

Business management consulting services provided to pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business management and business management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business consulting services provided to the healthcare industry in the nature of the creation, collection, analys...

Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition
precision advance the cell & gene therapy collective

General Information


Serial Number90558538
Word MarkPRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE
Filing DateWednesday, March 3, 2021
Status700 - REGISTERED
Status DateTuesday, July 26, 2022
Registration Number6800412
Registration DateTuesday, July 26, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements


Goods and ServicesProviding non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry
Goods and ServicesBusiness management consulting services provided to pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; business management and business management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; business consulting services provided to the healthcare industry in the nature of the creation, collection, analysis, and reporting of data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition
Disclaimer with Predetermined Text"CELL & GENE THERAPY COLLECTIVE"
Goods and ServicesScientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, food and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, health insurance, food and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and food and nutrition

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code035
First Use Anywhere DateThursday, January 14, 2021
First Use In Commerce DateThursday, January 14, 2021

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code041
First Use Anywhere DateThursday, January 14, 2021
First Use In Commerce DateThursday, January 14, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code042
First Use Anywhere DateThursday, January 14, 2021
First Use In Commerce DateThursday, January 14, 2021

Trademark Owner History


Party NamePrecision Medicine Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814

Party NamePrecision Medicine Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814

Party NamePrecision Medicine Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814

Trademark Events


Event DateEvent Description
Tuesday, July 26, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 26, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 4, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 29, 2021COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Thursday, July 29, 2021ASSIGNED TO LIE
Monday, July 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 22, 2021NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, July 22, 2021EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, July 22, 2021COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, July 22, 2021EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, July 21, 2021ASSIGNED TO EXAMINER
Wednesday, June 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 6, 2021NEW APPLICATION ENTERED IN TRAM